Eikon Therapeutics, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Eikon Therapeutics, Inc.'s yearly results, compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
Cash quality
Profit Cash Ratio
—Data incomplete
Self-Funding Ratio
—Data incomplete
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
—Data incomplete
Growth Efficiency Ratio
—Data incomplete
Asset Productivity Ratio
—Data incomplete
Balance-sheet strength
Debt Due Cover Ratio
-18.8×Operating cash was negative last year, while some debt falls due within a year.
Lower than 53% of Healthcare companies in United States.
Cash Cushion Ratio
+18%Cash, after subtracting all debt, equals 18% of its market value (net cash).
Higher than 60% of Healthcare companies in United States.
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (10)
Eikon Therapeutics, Inc. made a loss over the last year. Eikon Therapeutics, Inc. owes $0.40 for every $1 it owns. Eikon Therapeutics, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossEikon Therapeutics, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
0.96The share price is 0.96 times Eikon Therapeutics, Inc.'s book value per share, lower than 79% of Healthcare companies in United States.
Market cap
$446 MThe total market value of all of Eikon Therapeutics, Inc.'s shares at today's price (share price × number of shares), larger than 53% of Healthcare companies in United States. PosiCap size class: Mini Cap.
Net worth (book value)
$466 MWhat Eikon Therapeutics, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$8.61Net worth divided by the number of shares. The share price of $8.24 is 1.0 times this, which is the P/B above.
Owes vs Owns
0.40×Eikon Therapeutics, Inc. owes $0.40 for every $1 it owns (low), lower than 51% of Healthcare companies in United States.
Dividend yield
NoneEikon Therapeutics, Inc. does not currently pay a dividend.
Profit growth
LossEikon Therapeutics, Inc. made a loss in each of the last two years.
Interest cover
Not coveredEikon Therapeutics, Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net cashEikon Therapeutics, Inc. held $79 M more cash than debt (net cash) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Eikon Therapeutics, Inc.: $446 M ÷ $466 M (30 Jun 2026) = 1.0.
How much does Eikon Therapeutics, Inc. owe compared with what it owns?
Eikon Therapeutics, Inc. owes $0.40 for every $1 it owns (low), lower than 51% of Healthcare companies in United States.
Does Eikon Therapeutics, Inc. pay a dividend?
No. Eikon Therapeutics, Inc. does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.